Evaluation of non-invasive widefield OCT angiopgraphy

Evaluation of non-invasive widefield OCT angiopgraphy - Evangio

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00022461

Enrollment

Registered

2020-07-15

Start date

2020-10-06

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

H36.0 H34.8

Interventions

Group 1: OCT and fluorescein angiography

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients with diabetic retinopathy or retinal vein occlusion where fluorescein angiogrpahy is planned

Exclusion criteria

Exclusion criteria: - reduced general condition of health, inability to sit through examination - severe chronic diseases and/or psychic conditions that will severely reduce cooperative participation - severe optic opacities reducing retinal examinability - prisoners, institutionalized patients - confirmed or suspected fluorescein allerg

Design outcomes

Primary

Measure	Time frame
Diagnostic accuracy OCTA vs FAG	—

Secondary

Measure	Time frame
- Comparison of field of view - Unwanted side-effects	—

Countries

Germany

Contacts

Public ContactClaus von der Burchard

Universitätsaugenklinik Kiel

claus.vonderburchard@uksh.de+49 431 500 24201

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026